Another theoretical possibility of targeting sequences in cis to modulate splicing is the pharmacological modulation of RNA editing enzymes, such as ADAR which has been shown to play a role in GSK3B missplicing in CML [131]. Here, ADAR is linked to chronic myelogenous leukemia, BCR-ABL1 positive.